nodes	percent_of_prediction	percent_of_DWPC	metapath
Alvimopan—Quinapril—Ramipril—type 1 diabetes mellitus	0.498	0.512	CrCrCtD
Alvimopan—Benazepril—Ramipril—type 1 diabetes mellitus	0.474	0.488	CrCrCtD
Alvimopan—Quinapril—ACE—type 1 diabetes mellitus	0.00157	0.485	CrCbGaD
Alvimopan—Benazepril—ACE—type 1 diabetes mellitus	0.00137	0.422	CrCbGaD
Alvimopan—Ketoprofen—ALB—type 1 diabetes mellitus	0.000299	0.0925	CrCbGaD
Alvimopan—OPRD1—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00014	0.00566	CbGpPWpGaD
Alvimopan—OPRK1—Peptide ligand-binding receptors—CXCL10—type 1 diabetes mellitus	0.000138	0.0056	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.000138	0.00558	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.000136	0.00551	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.000136	0.00551	CbGpPWpGaD
Alvimopan—OPRD1—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	0.000133	0.00539	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.000131	0.00533	CbGpPWpGaD
Alvimopan—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00013	0.00525	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.000128	0.00518	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.000127	0.00516	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.000127	0.00513	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.000124	0.00502	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.000123	0.00497	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.000123	0.00497	CbGpPWpGaD
Alvimopan—OPRD1—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.000122	0.00495	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—SST—type 1 diabetes mellitus	0.000119	0.00481	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—CXCL10—type 1 diabetes mellitus	0.000117	0.00473	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	0.000117	0.00473	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.000115	0.00467	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.000112	0.00452	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.000111	0.0045	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00011	0.00447	CbGpPWpGaD
Alvimopan—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00011	0.00444	CbGpPWpGaD
Alvimopan—OPRK1—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.000107	0.00434	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.000106	0.00428	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.000105	0.00425	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.000104	0.0042	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.000104	0.0042	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—CD4—type 1 diabetes mellitus	0.000103	0.00419	CbGpPWpGaD
Alvimopan—OPRD1—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	0.000103	0.00418	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	9.86e-05	0.00399	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	9.74e-05	0.00395	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—SST—type 1 diabetes mellitus	9.69e-05	0.00393	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	9.68e-05	0.00392	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	9.65e-05	0.00391	CbGpPWpGaD
Alvimopan—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	9.57e-05	0.00388	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—IL1B—type 1 diabetes mellitus	9.55e-05	0.00387	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	9.43e-05	0.00382	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	9.39e-05	0.0038	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	9.27e-05	0.00376	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	9.06e-05	0.00367	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	9.05e-05	0.00366	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—GCG—type 1 diabetes mellitus	8.64e-05	0.0035	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—SST—type 1 diabetes mellitus	8.5e-05	0.00344	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	8.46e-05	0.00343	CbGpPWpGaD
Alvimopan—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	8.39e-05	0.0034	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	8.2e-05	0.00332	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	8.18e-05	0.00331	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	8.05e-05	0.00326	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	7.99e-05	0.00324	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	7.9e-05	0.0032	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	7.84e-05	0.00318	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	7.64e-05	0.0031	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—GCG—type 1 diabetes mellitus	7.58e-05	0.00307	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	7.43e-05	0.00301	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—GAL—type 1 diabetes mellitus	7.26e-05	0.00294	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	7.19e-05	0.00291	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—SST—type 1 diabetes mellitus	7.18e-05	0.00291	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	7.18e-05	0.00291	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	7.18e-05	0.00291	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	7.15e-05	0.0029	CbGpPWpGaD
Alvimopan—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	7.09e-05	0.00287	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	7.06e-05	0.00286	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	7.01e-05	0.00284	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	6.93e-05	0.00281	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	6.75e-05	0.00273	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	6.67e-05	0.0027	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	6.51e-05	0.00264	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—GCG—type 1 diabetes mellitus	6.4e-05	0.00259	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—GAL—type 1 diabetes mellitus	6.36e-05	0.00258	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	6.29e-05	0.00255	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	6.29e-05	0.00255	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	6.25e-05	0.00253	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	6.24e-05	0.00253	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	6.08e-05	0.00246	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	6.06e-05	0.00245	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	5.97e-05	0.00242	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	5.92e-05	0.0024	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	5.92e-05	0.0024	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	5.86e-05	0.00237	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	5.85e-05	0.00237	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	5.67e-05	0.0023	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—IL6—type 1 diabetes mellitus	5.6e-05	0.00227	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	5.51e-05	0.00223	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—SST—type 1 diabetes mellitus	5.48e-05	0.00222	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	5.48e-05	0.00222	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	5.47e-05	0.00222	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	5.45e-05	0.00221	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—GAL—type 1 diabetes mellitus	5.38e-05	0.00218	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	5.32e-05	0.00215	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	5.32e-05	0.00215	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	5.31e-05	0.00215	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	5e-05	0.00203	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—SST—type 1 diabetes mellitus	4.97e-05	0.00202	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	4.97e-05	0.00201	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	4.95e-05	0.00201	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	4.94e-05	0.002	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	4.88e-05	0.00198	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—SST—type 1 diabetes mellitus	4.8e-05	0.00195	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	4.78e-05	0.00194	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	4.7e-05	0.0019	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	4.63e-05	0.00188	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	4.62e-05	0.00187	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	4.56e-05	0.00185	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	4.55e-05	0.00184	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	4.49e-05	0.00182	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—GCG—type 1 diabetes mellitus	4.43e-05	0.0018	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—SST—type 1 diabetes mellitus	4.36e-05	0.00177	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	4.34e-05	0.00176	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—GAL—type 1 diabetes mellitus	4.29e-05	0.00174	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	4.28e-05	0.00173	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	4.27e-05	0.00173	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL20—type 1 diabetes mellitus	4.24e-05	0.00172	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL11—type 1 diabetes mellitus	4.24e-05	0.00172	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	4.2e-05	0.0017	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	4.14e-05	0.00168	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	4.13e-05	0.00167	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	4.12e-05	0.00167	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—SST—type 1 diabetes mellitus	4.06e-05	0.00164	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	4.04e-05	0.00164	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	4e-05	0.00162	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	3.99e-05	0.00162	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	3.99e-05	0.00161	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—GCG—type 1 diabetes mellitus	3.89e-05	0.00157	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—GAL—type 1 diabetes mellitus	3.76e-05	0.00152	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	3.74e-05	0.00152	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL11—type 1 diabetes mellitus	3.72e-05	0.00151	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL20—type 1 diabetes mellitus	3.72e-05	0.00151	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—SST—type 1 diabetes mellitus	3.69e-05	0.00149	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	3.67e-05	0.00149	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	3.63e-05	0.00147	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	3.62e-05	0.00147	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	3.62e-05	0.00147	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	3.58e-05	0.00145	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	3.53e-05	0.00143	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	3.49e-05	0.00142	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	3.48e-05	0.00141	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	3.48e-05	0.00141	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	3.38e-05	0.00137	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	3.37e-05	0.00137	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	3.37e-05	0.00136	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IAPP—type 1 diabetes mellitus	3.35e-05	0.00136	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—APOC3—type 1 diabetes mellitus	3.35e-05	0.00136	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—GCG—type 1 diabetes mellitus	3.29e-05	0.00133	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	3.21e-05	0.0013	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GAL—type 1 diabetes mellitus	3.18e-05	0.00129	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	3.16e-05	0.00128	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	3.16e-05	0.00128	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL20—type 1 diabetes mellitus	3.14e-05	0.00127	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL11—type 1 diabetes mellitus	3.14e-05	0.00127	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	3.14e-05	0.00127	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	3.09e-05	0.00125	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	3.07e-05	0.00124	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	3.06e-05	0.00124	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	3.05e-05	0.00124	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	2.95e-05	0.0012	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.95e-05	0.0012	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SST—type 1 diabetes mellitus	2.94e-05	0.00119	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.93e-05	0.00119	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.93e-05	0.00119	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.93e-05	0.00119	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.81e-05	0.00114	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.77e-05	0.00112	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.65e-05	0.00107	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—GCG—type 1 diabetes mellitus	2.62e-05	0.00106	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.62e-05	0.00106	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.58e-05	0.00104	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SST—type 1 diabetes mellitus	2.58e-05	0.00104	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.57e-05	0.00104	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.52e-05	0.00102	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.5e-05	0.00101	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.48e-05	0.001	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.48e-05	0.001	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.45e-05	0.000992	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.44e-05	0.000989	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.38e-05	0.000962	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.34e-05	0.000948	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—GCG—type 1 diabetes mellitus	2.3e-05	0.00093	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.23e-05	0.000902	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.22e-05	0.000898	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.21e-05	0.000896	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SST—type 1 diabetes mellitus	2.18e-05	0.000882	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.17e-05	0.000878	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.15e-05	0.00087	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.14e-05	0.000867	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CD86—type 1 diabetes mellitus	2.13e-05	0.000865	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	2.04e-05	0.000826	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—E2F1—type 1 diabetes mellitus	2.03e-05	0.000821	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.95e-05	0.000791	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.94e-05	0.000788	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GCG—type 1 diabetes mellitus	1.94e-05	0.000786	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.93e-05	0.00078	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.89e-05	0.000767	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.87e-05	0.000758	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.87e-05	0.000757	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.87e-05	0.000756	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.85e-05	0.00075	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.81e-05	0.000735	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.81e-05	0.000733	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.79e-05	0.000724	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.78e-05	0.00072	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.69e-05	0.000684	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.66e-05	0.000673	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.65e-05	0.000668	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.64e-05	0.000666	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.64e-05	0.000663	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.62e-05	0.000658	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.58e-05	0.000641	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.56e-05	0.000631	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.51e-05	0.000612	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.5e-05	0.000608	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—INS—type 1 diabetes mellitus	1.47e-05	0.000596	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.43e-05	0.000578	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.42e-05	0.000577	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.42e-05	0.000574	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.4e-05	0.000568	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.38e-05	0.00056	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.37e-05	0.000556	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.37e-05	0.000553	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.31e-05	0.000533	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.29e-05	0.000523	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—INS—type 1 diabetes mellitus	1.29e-05	0.000523	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.25e-05	0.000506	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.24e-05	0.000503	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.15e-05	0.000468	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.15e-05	0.000467	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.13e-05	0.000458	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.1e-05	0.000444	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	1.09e-05	0.000443	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—INS—type 1 diabetes mellitus	1.09e-05	0.000442	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.09e-05	0.000441	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.05e-05	0.000427	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.05e-05	0.000425	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.74e-06	0.000395	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.61e-06	0.000389	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL2—type 1 diabetes mellitus	9.59e-06	0.000389	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.56e-06	0.000387	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.54e-06	0.000387	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	9.21e-06	0.000373	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.37e-06	0.000339	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.12e-06	0.000329	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	8.11e-06	0.000328	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.07e-06	0.000327	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.07e-06	0.000327	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.34e-06	0.000297	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.82e-06	0.000276	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	6.43e-06	0.000261	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.2e-06	0.000251	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL6—type 1 diabetes mellitus	5.64e-06	0.000228	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	4.77e-06	0.000193	CbGpPWpGaD
